FOR TRANSLATIONAL RESEARCH IN NUCLEAR MEDICINE.
Arronax Nantes brings together all stakeholders in Nantes working on research and development in nuclear medicine.
This more particularly include the GIP ARRONAX, the laboratories Ceisam, CEMA-Oniris, CRCINA, LS2N, Subatech, the CRIP-Oniris core facility and the Nuclear Medicine departments of the University Hospital of Nantes and the ICO.
Arronax Nantes is a stakeholder in the I-SITE NExT, in close collaboration with the LabEx IRON and the SIRIC ILIAD.
our publications
New results on proton-induced reactions on vanadium for 47Sc production and the impact of level densities on theoretical cross sections, Barbaro, F. and Canton, L. and Carante, M. P. and Colombi, A. and De Dominicis, L. and Fontana, A. and Haddad, F. and Mou, L. and Pupillo, G., Phys. Rev. C, 25 oct 2021;104:044619. 10.1103/PhysRevC.104.044619
- Terbium Medical Radioisotope Production: Laser Resonance Ionization Scheme Development, Gadelshin VM, Formento Cavaier R, Haddad F, Heinke R, Stora T, Studer D, et al., Front Med. 12 oct 2021;8:727557. https://doi.org/10.3389/fmed.2021.727557
our news
News from the European project ENSAR 2
11/10/21
Nantes research on astatine in the spotlight
27/09/21
PRISMAP : building a European network for medical radionuclides
21/09/21
A Raman/microscopy equipment for radiobiology
20/09/21
A possible way to produce 67Cu for theranostic applications
22/07/21
